• ABOUT US
    • Royal Canin Academy Digital Library
    • Royal Canin Academy learning platform
    • Royal Canin Campus tour
    • Royal Canin Foundation
    • Royal Canin Career

  • Contact Us
image/svg+xml
HomeVeterinaryDiet induced reduction of left ventricular wall thickness, Troponin-I and IGF-1 in cats with asymptomatic hypertrophic cardiomyopathy

Diet induced reduction of left ventricular wall thickness, Troponin-I and IGF-1 in cats with asymptomatic hypertrophic cardiomyopathy

Authors:  van Hoek, I, Hodgkiss-Geere, H , Bode, E, Hamilton-Elliott, J, Motskula, P, Palermo, V, Martinez-Pereira, Y, Culshaw, G, Laxalde, J and Dukes McEwan, Joanna

Journal of Veterinary Internal Medicine, October 2020; 34 (6). pp. 2197-2210. ISSN 0891-6640

doi.org/10.1111/jvim.15925

Share on social media

    • VETERINARY TEAMS
    • VET FOCUS
      • Royal Canin Academy Digital Library
      • Royal Canin Academy learning platform
      • Royal Canin Campus tour
      • Royal Canin Foundation

      • Royal Canin Career
      topnav dogs on couch
    • Any Questions?

      Need help? Visit our Contact Us page or reach us directly.

      • By Email
      • About us
    Reading time5 - 15 min

    Abstract

    Background

    Cats with subclinical hypertrophic cardiomyopathy (sHCM) have elevated serum insulin and serum amyloid A concentrations correlating with the degree of cardiac hypertrophy. Diet might affect these and other cardiac variables. 

    Objectives

    Evaluate the effect of a complete, balanced diet with restricted starch and supplemented with eicosapentaenoic acid + docosahexaenoic acid (EPA + DHA) on echocardiographic variables and cardiac biomarkers in cats with sHCM. 

    Animals

    Forty-four client-owned cats with sHCM. 

    Methods

    A prospective, randomized, double-blind, multicenter study enrolled cats with end-diastole interventricular septum thickness (IVSd) or left ventricular wall thickness (LVWd) ≥6 mm, or both. Nonsedated, fasted cats were examined at baseline and after 6 and 12 months of Test (restricted starch and EPA + DHA supplements) (n = 23) or Control (unrestricted starch without EPA + DHA supplementation) (n = 21) diet. Assessments included auscultation, body weight, body condition score, echocardiography and blood analysis. Linear and generalized mixed models analyzed diet, time and diet * time interactions (5% significance level).

    Results

    No differences between diet groups were significant for any variable at any timepoint. There were significant decreases in the Test but not Control group in maximum IVSd (P = .03), maximum LVWd (P = .02) and insulin-like growth factor-1 levels (P = .04) after 12 months, and in ultrasensitive cardiac troponin I (cTnI) (P = .001) after 6 months; effect sizes (95% confidence interval) were 0.53 (0.09; 0.99), 0.63 (0.18; 1.09), 0.61 (0.16; 1.07), and 0.37 (-0.06; 0.8), respectively. 

    Conclusion and Clinical Importance

    Cats with sHCM fed Test diet had significant decreases in echocardiographic variables of sHCM and in cTnI and IGF-1.

     

    Access the article